News | July 15, 2025
WHO, ITU, and WIPO release new report on AI use in traditional medicine
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Launched in Thailand, the ASEAN hub, marking an early entry into the fast-growing combination therapy market (DPP-4 and SGLT-2 inhibitor combination) with strong potential for market leadership
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
IMCD India’s innovative formulations bring the Skinification trend to life with cutting-edge solutions across beauty and personal care
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Biocon Biologics is among the two pharmaceutical companies from India in the 93 companies featuring on the Asia IP Elite 2024 list
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
Subscribe To Our Newsletter & Stay Updated
